Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Front Immunol. 2018 Feb 27;9:331. doi: 10.3389/fimmu.2018.00331. eCollection 2018.
INTRODUCTION: Conditioning regimens preceding allogeneic stem cell transplantation (alloSCT) can cause tissue damage and acceleration of the development of graft-versus-host disease (GVHD). T-cell-depleted alloSCT with postponed donor lymphocyte infusion (DLI) may reduce GVHD, because tissue injury can be restored at the time of DLI. In this study, we investigated the presence of tissue injury and inflammation in skin during the period of hematologic recovery and immune reconstitution after alloSCT. METHODS: Skin biopsies were immunohistochemically stained for HLA class II, CD1a, CD11c, CD40, CD54, CD68, CD86, CD206, CD3, and CD8. HLA class II-expressing cells were characterized as activated T-cells, antigen-presenting cells (APCs), or tissue repairing macrophages. In sex-mismatched patient and donor couples, origin of cells was determined by multiplex analysis combining XY-FISH and fluorescent immunohistochemistry. RESULTS: No inflammatory environment due to pretransplant conditioning was detected at the time of alloSCT, irrespective of the conditioning regimen. An increase in HLA class II-positive macrophages and CD3 T-cells was observed 12-24 weeks after myeloablative alloSCT, but these macrophages did not show signs of interaction with the co-localized T-cells. In contrast, during GVHD, an increase in HLA class II-expressing cells coinciding with T-cell interaction was observed, resulting in an overt inflammatory reaction with the presence of activated APC, activated donor T-cells, and localized upregulation of HLA class II expression on epidermal cells. In the absence of GVHD, patient derived macrophages were gradually replaced by donor-derived macrophages although patient-derived macrophages were detectable even 24 weeks after alloSCT. CONCLUSION: Conditioning regimens cause tissue damage in the skin, but this does not result in a local increase of activated APC. In contrast to the inflamed situation in GVHD, when interaction takes place between activated APC and donor T-cells, the tissue damage caused by myeloablative alloSCT results in dermal recruitment of HLA class II-positive tissue repairing macrophages co-existing with increased numbers of patient- and donor-derived T-cells, but without signs of specific interaction and initiation of an immune response. Thus, the local skin damage caused by the conditioning regimen appears to be insufficient as single factor to provoke GVHD induction.
简介:异基因造血干细胞移植(alloSCT)前的预处理方案可导致组织损伤和移植物抗宿主病(GVHD)的加速发展。用延迟供者淋巴细胞输注(DLI)的 T 细胞耗竭 alloSCT 可能会降低 GVHD,因为在 DLI 时可以恢复组织损伤。在这项研究中,我们研究了 alloSCT 后造血恢复和免疫重建期间皮肤中的组织损伤和炎症。 方法:对皮肤活检进行 HLA Ⅱ类、CD1a、CD11c、CD40、CD54、CD68、CD86、CD206、CD3 和 CD8 的免疫组化染色。表达 HLA Ⅱ类的细胞被鉴定为活化的 T 细胞、抗原提呈细胞(APCs)或组织修复巨噬细胞。在性染色体不相容的患者和供体夫妇中,通过结合 XY-FISH 和荧光免疫组化的多重分析确定细胞的起源。 结果:无论预处理方案如何,在 alloSCT 时均未检测到由于预处理引起的炎症环境。在清髓性 alloSCT 后 12-24 周,观察到 HLA Ⅱ类阳性巨噬细胞和 CD3 T 细胞的增加,但这些巨噬细胞没有与共定位 T 细胞相互作用的迹象。相反,在 GVHD 期间,观察到与 T 细胞相互作用的 HLA Ⅱ类表达细胞增加,导致存在活化的 APC、活化的供体 T 细胞和表皮细胞 HLA Ⅱ类表达的局部上调的明显炎症反应。在没有 GVHD 的情况下,虽然在 alloSCT 后 24 周仍可检测到患者来源的巨噬细胞,但患者来源的巨噬细胞逐渐被供体来源的巨噬细胞取代。 结论:预处理方案会导致皮肤组织损伤,但不会导致活化的 APC 局部增加。与 GVHD 中的炎症情况不同,当活化的 APC 与供体 T 细胞相互作用时,清髓性 alloSCT 引起的组织损伤会导致 HLA Ⅱ类阳性组织修复巨噬细胞募集到真皮中,同时伴有患者和供体来源的 T 细胞数量增加,但没有特异性相互作用和免疫反应的迹象。因此,预处理方案引起的局部皮肤损伤似乎不足以作为单一因素引发 GVHD 的诱导。
Med J Islam Repub Iran. 2021-11-2
Immunology. 2017-11
Inflammation. 2017-8
Biol Blood Marrow Transplant. 2017-3
Front Immunol. 2016-11-29
J Leukoc Biol. 2013-3-15
Biol Blood Marrow Transplant. 2013-3-1